Not exact matches
With the exception of mammography, there is no federal regulation of
radiation dose for medical tests, leaving the appropriate use of
heart imaging in the hands of clinicians and imaging facilities.
The patent - pending technology, which uses detectors at the
heart of the Large Hadron Collider at CERN alongside world - first
radiation - hard CMOS imagers, will reduce
dose uncertainties from several centimetres to just a few millimetres.
Recent studies have shown women with cancer in the left breast are at higher risk of
heart disease, and that the risk increases proportionately with the
dose of
radiation the
heart is exposed to during treatment.
The researchers found that patients capable of holding their breath over the course of treatment had a 90 percent disease - free survival, and a 96 percent overall survival, with a median reduction in
radiation dose to the
heart of 62 percent.
Additional work recently presented at the 2014 American Society for
Radiation Oncology in San Francisco carried the work further in order to determine whether protection from the additional
radiation dose in fact translated to a reduction in ischemic
heart disease.
Studies have shown that the risk of
heart disease is higher in this group of women after
radiation treatment because it can be difficult to ensure that a sufficient
dose of
radiation is delivered to the left breast while adequately shielding the
heart from exposure.
There were only modest acute changes in cardiac biomarkers and electrocardiograms and there were no clinically significant cardiac events in patients with high -
dose radiation exposure to the
heart following thoracic
radiation therapy (RT) and short - term follow - up.
In a new study, experts found that most American labs do not comply with
radiation dose recommendations for
heart tests.
This type of treatment shapes the
radiation dose around the shape of the tumor with such precision that it leaves nearby structures (eyes,
heart, etc.) unharmed, minimizing side effects.